| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.0M | -90.0% |
| R&D Expense | $139.1M | +131.8% |
| SG&A Expense | $29.7M | +73.8% |
| Operating Income | -$163.9M | -341.2% |
| Pre-tax Income | -$156.6M | -325.2% |
| Income Tax | $429K | +42.5% |
| Net Income | -$157.0M | -322.9% |
| EPS (Basic) | -$11.89 | +51.0% |
| EPS (Diluted) | -$11.89 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $319.7M | +462.4% |
| Short-term Investments | $31.0M | — |
| Current Assets | $355.9M | +495.1% |
| Total Assets | $370.0M | +442.6% |
| Current Liabilities | $57.3M | +146.3% |
| Total Liabilities | $57.5M | +31.3% |
| Stockholders' Equity | $312.5M | +238.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$119.7M | -292.0% |
| Capital Expenditures | $131K | +670.6% |
| Investing Cash Flow | -$30.6M | — |
| Financing Cash Flow | $413.0M | +1952.9% |
| Free Cash Flow | -$119.8M | -292.2% |
| +51.0% |